No, I think that their use of existing technology is exactly the heart of the issue. They claim to have made a breakthrough in how blood tests are conducted that allows them to run a large set of blood tests on a tiny fingerprick blood sample. An investigative journalist then reported that they're not using this technology at all, and all the tests they sell commercially are regular venous blood draws run through testing machines purchased from other companies.
If Theranos is not using their fingerprick blood testing technology, then they are not using their technology commercially at all. So if this is true, then they're a company that's been in business 11 years, has a massive valuation, and has not developed a commercially viable technology yet. It's as if a web search company like Google had been around 11 years, was worth >$1 billion, and then was found to be exclusively using and rebranding Microsoft's search technology instead. It's a scandal.
Theranos' valuation cannot be sustained anywhere near its current value simply by selling blood tests conducted on equipment manufactured by other firms. Theranos' claim to fame is a breakthrough in fingertip-prick blood testing technology, and they have no way to differentiate themselves in the market without this breakthrough technology - their investment value cannot be sustained simply by reselling technology made by other firms.